EUVIMEDEUVIMED entdecken
Crossref

Charting a course for the expanded application of mRNA vaccine technology

Myriam Mendila

Nucleic Acid Insights · 2024

DOI: 10.18609/nai.2024.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Insights, 2024. Verfasst von Myriam Mendila.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A pioneer in the development of mRNA technology, CureVac has spent more than two decades in exploring its potential in both prophylactic and therapeutic vaccine settings. David McCall, Senior Editor, Nucleic Acid Insights, discusses the promise of next-generation approaches with Chief Development Officer, Myriam Mendila.

Zitieren

APA

Mendila, M. (2024). Charting a course for the expanded application of mRNA vaccine technology. Nucleic Acid Insights. https://doi.org/10.18609/nai.2024.001

Vancouver

Mendila M. Charting a course for the expanded application of mRNA vaccine technology. Nucleic Acid Insights. 2024. doi:10.18609/nai.2024.001

BibTeX
@article{Mendila2024,
  author = {Mendila, Myriam},
  title = {Charting a course for the expanded application of mRNA vaccine technology},
  journal = {Nucleic Acid Insights},
  year = {2024},
  doi = {10.18609/nai.2024.001}
}
Kostenlos starten →